Inventor
BATT DOUGLAS G
US45 patents
⚠️ This page may combine multiple inventors who share the name “BATT DOUGLAS G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
23 patentsUS10000480B2Jun 19, 2018
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO20 citations94
US8362065B2Jan 29, 2013
Carbazole carboxamide compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO32 citations92
US7163937B2Jan 16, 2007
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO29 citations92
US7378409B2May 27, 2008
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO20 citations83
US9815859B2Nov 14, 2017
Tricyclic sulfones as RORγ modulators
BRISTOL MYERS SQUIBB CO11 citations82
US9334290B2May 10, 2016
Substituted tetrahydrocarbazole and carbazole carboxamide compounds
BRISTOL MYERS SQUIBB CO5 citations82
US7482335B2Jan 27, 2009
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO6 citations73
US10435369B2Oct 8, 2019
Tricyclic sulfones as ROR gamma modulators
BRISTOL MYERS SQUIBB CO6 citations71
US11053197B2Jul 6, 2021
Carbazole derivatives
BRISTOL MYERS SQUIBB CO0 citations62
US10968177B2Apr 6, 2021
Tricyclic sulfones as RORγ modulators
BRISTOL MYERS SQUIBB CO0 citations52
US7829571B2Nov 9, 2010
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US7381738B2Jun 3, 2008
Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO1 citations52
US7291744B2Nov 6, 2007
N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO2 citations52
US6919356B2Jul 19, 2005
N-substituted heterocyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO2 citations52
US10676434B2Jun 9, 2020
Carbazole derivatives
BRISTOL MYERS SQUIBB CO0 citations51
US10435415B2Oct 8, 2019
Substituted tetrahydrocarbazole and carbazole carboxamide compounds
BRISTOL MYERS SQUIBB CO0 citations51
US10266491B2Apr 23, 2019
Carbazole derivatives
BRISTOL MYERS SQUIBB CO0 citations51
US10106559B2Oct 23, 2018
Substituted tetrahydrocarbazole and carbazole carboxamide compounds
BRISTOL MYERS SQUIBB CO0 citations51
US9714234B2Jul 25, 2017
Carbazole carboxamide compounds
BRISTOL MYERS SQUIBB CO1 citations49
US7288563B2Oct 30, 2007
Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations42
US7230022B2Jun 12, 2007
Substituted fused bicyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations42
US10214537B2Feb 26, 2019
Bicyclic heteroaryl amine compounds
BRISTOL MYERS SQUIBB CO0 citations41
US7479496B2Jan 20, 2009
Substituted spiro azabicyclics as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations41
DU PONT MERCK PHARMA
8 patentsUS5593994AJan 14, 1997
Prostaglandin synthase inhibitors
DU PONT MERCK PHARMA251 citations98
US5578609ANov 26, 1996
2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
DU PONT MERCK PHARMA20 citations91
US5523408AJun 4, 1996
2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
DU PONT MERCK PHARMA32 citations91
US5093351AMar 3, 1992
Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors
DU PONT MERCK PHARMA19 citations82
US5428040AJun 27, 1995
Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
DU PONT MERCK PHARMA10 citations73
US5393891AFeb 28, 1995
Immunoassay reagents and methods for detecting brequinar and analogs
DU PONT MERCK PHARMA11 citations73
US5026759AJun 25, 1991
2-substituted-1-naphthols as 5-lipoxygenase inhibitors
DU PONT MERCK PHARMA2 citations63
US5049570ASep 17, 1991
Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
DU PONT MERCK PHARMA4 citations61
DU PONT
6 patentsUS4833164AMay 23, 1989
2-substituted-1-naphthols, pharmaceutical compositions of, and their use as 5-lipoxygenase inhibitors
DU PONT19 citations82
US4985435AJan 15, 1991
2-substituted-1-naphthols as 5-lipoxygenase inhibitors
DU PONT2 citations63
US4985442AJan 15, 1991
2-substituted-1-naphthols as 5-lipoxygenase inhibitors
DU PONT1 citations63
US4859693AAug 22, 1989
Antiinflammatory carbinoloimidazoles
DU PONT2 citations61
US5006555AApr 9, 1991
Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors
DU PONT0 citations52
US4906636AMar 6, 1990
2-Substituted-1-naphthols as 5-lipoxygenase inhibitors
DU PONT0 citations52